Regulatory News: THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics of autoimmune diseases and theranostics, announces today its new financial calendar
Christian Policard is appointed Chairman of THERADIAG Simon Davière becomes Chief Executive Officer of THERADIAG Regulatory News: The Board of Directors of THERADIAG (ISIN: FR0004197747
Theradiag: Downward Adjustment of the Sales and Profitability Targets For 2026 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Regulatory News: THERADIAG (ISIN: FR0004197747, Ticker: ALTER) (Paris:ALTER), a company specializing in in vitro diagnostics and Theranostics, announces that Biosynex (ISIN: FR0011005933 Mnemonic:
Regulatory News: THERADIAG (ISIN: FR0004197747, Mnemonic: ALTER), a company specializing in in vitro diagnostics and theranostics, announces the launch of ez-Track1, a real Point-of-Care Testing (POCT)